Leukemia inhibitory factor increases the invasiveness of trophoblastic cells through integrated increase in the expression of adhesion molecules and pappalysin 1 with a concomitant decrease in the expression of tissue inhibitor of matrix metalloprot
about
Human Decidual Stromal Cells as a Component of the Implantation Niche and a Modulator of Maternal ImmunityLIF-STAT signaling and trophoblast biologyProvocative ideas on human placental biology: A prerequisite for prevention and treatment of neonatal health challenges.Interdependence of JAK-STAT and MAPK signaling pathways during EGF-mediated HTR-8/SVneo cell invasion.HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells.Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.LIF upregulates poFUT1 expression and promotes trophoblast cell migration and invasion at the fetal-maternal interfaceAlpha or beta human chorionic gonadotropin knockdown decrease BeWo cell fusion by down-regulating PKA and CREB activation.Dysregulated expression of IDO may cause unexplained recurrent spontaneous abortion through suppression of trophoblast cell proliferation and migration.Oncostatin M stimulates cell migration and proliferation by down-regulating E-cadherin in HTR8/SVneo cell line through STAT3 activation.LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway.Prospects of electrochemical immunosensors for early diagnosis of preeclampsia.STAT3 and ERK1/2 cross-talk in leukaemia inhibitory factor mediated trophoblastic JEG-3 cell invasion and expression of mucin 1 and Fos.The regulatory mechanisms of NG2/CSPG4 expression.Myofibroblasts are important contributors to human hepatocellular carcinoma: evidence for tumor promotion by proteome profiling.Leukemia inhibitory factor: roles in embryo implantation and in nonhormonal contraception.
P2860
Q26745137-6267E7FC-8F55-4767-9FED-6C5F2E30C93CQ26825942-9615F575-C51D-41B7-841D-66A1E121051AQ30235366-4A51273A-F99E-4379-81B6-0AC72D2F3FC8Q33728495-17716309-475B-4B96-8450-A78162AB935BQ35552029-32D761E6-2099-4D2D-B5CC-F699424A560CQ35655840-BF63A278-2C18-439E-8FD5-70E563A15B9AQ35679536-F4D58F7B-B0B5-47FC-A747-8DD3304C9E65Q35693347-89EE281A-7C2C-49C0-B20A-ADE366ED9C11Q36507598-B6E74A45-69EF-4B87-8C46-5B532F627867Q37361317-739E32EA-B5DA-4CF7-BFA0-D485CE97A041Q37718451-76A1F659-B05E-4360-A5BD-7A62B7883596Q38963975-9294B24B-6526-46A3-BA2D-F507F783B3FCQ39005979-A1C5AF0A-1B98-4D58-93D0-A094A1D36218Q39325532-B07344AA-C8D3-4173-8488-7455016DC2B6Q39335058-B3C5FAC1-77AB-4512-A626-3053ED78C26DQ55617573-B4FE2421-53E2-4986-9933-8BBA7AA542DC
P2860
Leukemia inhibitory factor increases the invasiveness of trophoblastic cells through integrated increase in the expression of adhesion molecules and pappalysin 1 with a concomitant decrease in the expression of tissue inhibitor of matrix metalloprot
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Leukemia inhibitory factor inc ...... nhibitor of matrix metalloprot
@en
Leukemia inhibitory factor inc ...... nhibitor of matrix metalloprot
@nl
type
label
Leukemia inhibitory factor inc ...... nhibitor of matrix metalloprot
@en
Leukemia inhibitory factor inc ...... nhibitor of matrix metalloprot
@nl
prefLabel
Leukemia inhibitory factor inc ...... nhibitor of matrix metalloprot
@en
Leukemia inhibitory factor inc ...... nhibitor of matrix metalloprot
@nl
P1476
Leukemia inhibitory factor inc ...... r of matrix metalloproteinases
@en
P2093
Nachiket Shembekar
P304
P356
10.1016/J.FERTNSTERT.2012.10.004
P407
P577
2012-11-02T00:00:00Z